Cargando…
Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy
Paclitaxel (PTX) has been used for cancer treatment for decades and has become one of the most successful chemotherapeutics in the clinic and financially. However, serious problems with its use still exist, owing to its poor solubility and non-selective toxicity. With respect to these issues, recent...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039396/ https://www.ncbi.nlm.nih.gov/pubmed/33855017 http://dx.doi.org/10.3389/fcell.2021.626910 |